May 15, 2026 by Medigroup
Nearly every physician office, surgery centre, and non-acute healthcare facility in the United States has access to a group purchasing organization. That fact is so often repeated in healthcare supply chain conversations that it has stopped surprising anyone. What does surprise people is what comes next.
Most non-acute providers are not getting close to full value from their GPO contracts. Not because the contracts are bad, but because alignment — between the GPO, the purchasing process, and the clinicians actually using the supplies — is far harder to achieve than simply signing on.
In 2026, that gap between membership and alignment is costing smaller providers more than most realize.
Here is what the standard benefits of GPO conversation tends to skip past. A peer reviewed study published in the Journal of Public Economics (2025) offered some of the first hard empirical evidence on what GPO scale actually delivers:
But the same research surfaced something worth sitting with. Decades of prior debate found that many claimed GPO savings figures were based on estimates and perceptions rather than hard transactional data.
The implication is not that GPOs fail to deliver. It is that the value depends entirely on how actively a facility uses its membership. Contract access and contract utilization are two very different things, and the gap between them is where savings quietly disappear — especially in non-acute settings where no one is watching the numbers full time.
Physician preference items are one of the most underexamined cost drivers in non-acute healthcare supply chain management. These are products, devices, and consumables that individual clinicians request by brand or habit, often because that is what they trained with rather than because evidence clearly supports their superiority.
The scale of the problem:
This is not a blame exercise. Clinicians have legitimate expertise about what works in their hands. The problem is the absence of a structured process for translating that expertise into purchasing decisions that also serve the organization’s financial goals. Non-acute facilities that bring clinical and administrative voices into the same conversation about supply decisions consistently manage this better than those treating the two as entirely separate concerns.
One of the more unexpected recent findings in healthcare group purchasing comes from a 2024 Health Affairs Scholar study examining how GPO contracting practices influenced adoption of biosimilar drugs — lower cost alternatives to expensive biologic medications.
Uptake has been slow across much of the non-acute sector. The study found:
The takeaway is direct. Passive membership yields passive results. Active alignment, where the GPO’s contracting strategy integrates with a facility’s clinical purchasing decisions, produces measurably different financial outcomes. This is what GPO alignment actually means in practice: not access to a catalog, but shared strategy around how that catalog is used.
How Healthcare Supply Chain Management Is Redefining GPOs
The role of the medical GPO group purchasing organization is being quietly redefined. For most of their history, GPOs were aggregators: pool volume, negotiate price, provide contract access. The strategic side of procurement stayed with the buyer.
That model is under pressure from several directions at once:
Leading GPOs are expanding into early warning systems for supply disruptions, clinical value analysis support, and spend optimization tools. For physician offices and surgery centers without dedicated procurement staff, this kind of active GPO support is not just useful — it is the difference between managing supply costs strategically and simply reacting to them.
MediGroup’s Vision: GPO Alignment Built for Non-Acute Providers
At MediGroup, we built our entire model around the reality that physician offices, surgery centers, and non-acute facilities face the same supply chain pressures as large health systems, with a fraction of the internal resources to manage them.
Our view is straightforward:
For our members, supported GPO alignment means lower costs, fewer supply surprises, and more time for clinical and administrative staff to focus on patient care rather than purchasing decisions.
Healthcare group purchasing organizations have never been more important to non-acute provider financial performance, and the evidence has never been stronger. But the research is equally clear that membership alone is not the mechanism.
Supply costs represent a significant and growing share of operating expenses for physician offices and surgery centers, and that share is not shrinking. In an environment defined by margin pressure and supply volatility, the facilities that manage that spend with genuine GPO alignment will be in a materially stronger position than those still treating procurement as an afterthought.
Alignment means:
The gap between having a GPO and using one well is measurable. In 2026, it is increasingly the gap between non-acute facilities that are financially stable and those that are quietly struggling.